📊 CYPH Key Takeaways
Investment Thesis
Cypherpunk Technologies exhibits severe operational distress with negative operating income of -$41.1M against minimal revenue of $1.5M, indicating the company is not operationally viable. The reported net income of $4.8M appears to be driven by non-operating gains rather than business fundamentals, masking underlying deterioration. Negative free cash flow of -$44.0M combined with heavy cash burn and minimal revenue growth presents an unsustainable financial position.
CYPH Strengths
- Strong balance sheet with $153.5M stockholders' equity and minimal debt ($0M long-term debt)
- Exceptional liquidity with 35.56x current ratio providing runway for operations
- Positive net income and earnings per share growth (+103.9% YoY EPS)
CYPH Risks
- Severe operational losses with -$41.1M operating income on $1.5M revenue indicating business model failure
- Massive cash burn of -$44.0M annually with only $14.0M cash on hand providing <4 months of runway
- Net income likely driven by non-operating gains rather than business fundamentals, obscuring true operating performance
- Zero revenue growth (+0.0% YoY) despite being in pharmaceutical sector
- Heavy insider trading activity (22 Form 4 filings in 90 days) may indicate lack of confidence
Key Metrics to Watch
- Operating cash flow trajectory and burn rate sustainability
- Revenue growth acceleration from current 0% YoY stagnation
- Cash depletion timeline given -$44.0M annual FCF burn against $14.0M cash balance
CYPH Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 35.56x current ratio provides a solid financial cushion.
CYPH Profitability Ratios
CYPH vs Healthcare Sector
How CYPHERPUNK TECHNOLOGIES INC. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CYPH Balance Sheet & Liquidity
CYPH 5-Year Financial Trend
5-Year Trend Summary: CYPHERPUNK TECHNOLOGIES INC.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-1.81 indicates the company is currently unprofitable.
CYPH Growth Metrics (YoY)
CYPH Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2022 | $375.0K | -$10.9M | $-0.13 |
| Q2 2022 | $375.0K | -$9.4M | $-0.12 |
| Q1 2022 | $375.0K | -$9.1M | $-0.09 |
| Q3 2021 | $375.0K | -$7.1M | N/A |
| Q2 2021 | $375.0K | -$6.5M | N/A |
| Q1 2021 | $375.0K | -$6.3M | N/A |
| Q3 2020 | $375.0K | -$7.1M | $-0.09 |
| Q2 2020 | $375.0K | -$6.5M | $-0.12 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CYPH Capital Allocation
CYPH SEC Filings
Access official SEC EDGAR filings for CYPHERPUNK TECHNOLOGIES INC. (CIK: 0001509745)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CYPH
What is the AI rating for CYPH?
CYPHERPUNK TECHNOLOGIES INC. (CYPH) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CYPH's key strengths?
Strong balance sheet with $153.5M stockholders' equity and minimal debt ($0M long-term debt). Exceptional liquidity with 35.56x current ratio providing runway for operations.
What are the risks of investing in CYPH?
Severe operational losses with -$41.1M operating income on $1.5M revenue indicating business model failure. Massive cash burn of -$44.0M annually with only $14.0M cash on hand providing <4 months of runway.
What is CYPH's revenue and growth?
CYPHERPUNK TECHNOLOGIES INC. reported revenue of $1.5M.
Does CYPH pay dividends?
CYPHERPUNK TECHNOLOGIES INC. does not currently pay dividends.
Where can I find CYPH SEC filings?
Official SEC filings for CYPHERPUNK TECHNOLOGIES INC. (CIK: 0001509745) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CYPH's EPS?
CYPHERPUNK TECHNOLOGIES INC. has a diluted EPS of $0.07.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.